News | Radial Access | July 13, 2016

Study Affirms Radial Access as Default Approach for Inserting Stents

Results show reduced bleeding complications, death rates with radial over femoral access

radial access, inserting stents, JACC Cardiovascular Interventions study

July 13, 2016 — A new study in JACC: Cardiovascular Interventions supports access through the wrist, or radial access, as the default approach when inserting stents to restore blood flow in heart disease patients. Study results show radial access has fewer complications than access through the groin, or femoral access.

Researchers looked at 24 studies, enrolling 22,843 participants to conduct a comprehensive meta-analysis across the spectrum of heart disease. They determined there was "strong to very strong" evidence that major bleeding and vascular complications were reduced and "moderate to strong" evidence that all-cause death rates were reduced when using radial access versus femoral access.

Researchers concluded that the benefits of radial access support it being the default approach for all heart disease patients needing this procedure.

Radial access is a newer procedure and it involves a longer learning curve to develop the technical skills necessary. However, JACC: Cardiovascular Interventions Editor-in-Chief Spencer King, M.D., MACC, said, “As radial access is increasingly adopted, the benefits seen in trials have been weighed against the learning curve necessary for some operators. This most complete analysis of the value of radial access may convince some doubters to switch.”

For more information: www.interventions.onlinejacc.org


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now